Congratulations to Prof Marella de Bruijn, Associate Professor of Developmental Haematopoiesis, who has become the Director of the Oxford-MRC Doctoral Training Partnership.
Congratulations to Dr Beth Psaila, who has won a prestigious Fellowship at the L\u2019Or\u00e9al-UNESCO UK and Ireland For Women In Science awards. She was one of five scientists to receive the highly competitive award.
Oxfordshire Science Festival is back and RDM researchers are out in force engaging the public with their research. Join us in Oxford Town Hall on 17 and 18 June as we showcase research from across the department.
Researchers have found a way to identify rogue cancer cells which survive treatment after the rest of the tumour is destroyed, by using a new technique that enables them to identify and characterise individual cancer cells.
We are delighted to announce that researchers in RDM have been selected to take part in the Royal Society Summer Science Exhibition \u2013 a prestigious science festival that showcases the best of UK research.
Congratulations to all our prize winners at this year\u2019s WIMM Day. We were delighted to award Mike Barnkob, a DPhil student with Prof Vincenzo Cerundolo in the MRC Human Immunology Unit, the Ita Askonas Medal and Prize for his work on T cells in the tumour microenvironment.
The American Society of Hematology (ASH) and the European Hematology Association (EHA) have announced the names of 20 early-career hematologists who will participate in the joint 2017 Translational Research Training in Hematology (TRTH) program. These include Dr Alice Giustacchini (WIMM-NDCLS, Mead/Jacobsen Group) and Dr Lynn Quek (WIMM-NDCLS, Vyas Group). Congratulations to Alice and Lynn for being invited to take part in this prestigious scheme.
One of the great mysteries in biology is how the many different cell types that make up our bodies are derived from a single cell and from one DNA sequence, or genome.
Oxford, UK: 23 May, 2018: Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a \u00a36.9M Series A Financing. The round was led by Oxford Sciences Innovation who were joined by new investors RT Ventures, Borealis Ventures, Perivoli Innovations, along with further investment from all existing investors and Oxford University. Additionally, Borealis Managing Partner Phil Ferneau and Oxford Investment Consultants\u2019 Partner James Mallinson join Orbit\u2019s Board of Directors.
![](\"https://www.rdm.ox.ac.uk/news/marella-de-brujin-becomes-director-of-the-oxford-mrc-doctoral-training-partnership/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n